Skip to content
Research Article Open access CC BY 4.0

Stabilization of Prostate Cancer with Amanita phalloides: Intervals with 5-Alpha-Reductase Inhibitors and Melatonin to Circumvent Resistance: Case Report

Isolde Riede

Journal of Advances in Medicine and Medical Research · pp. 1–6 · Published 17 Aug 2016

10.9734/BJMMR/2016/27895

Abstract

Aims: Amanita phalloides contains alpha-amanitin, inhibiting RNApolymeraseII. Due to overexpression of switch genes in tumor cells, RNApolymeraseII is used to full extent there. Partial inhibition with amanitin influences tumor cell - but not normal cell - activity. A patient with diagnosed prostate cancer was treated successfully for six years with Amanita alone, prostate specific antigen levels increased slowly. However, the necessary dose for stabilization of the level increased during this time. To circumvent further habituation or resistance, other therapeutics were applied in intervals. Presentation of Case: Inhibitors of 5-alpha-reductase were applied in intervals of pausing Amanita. They can further stabilize the prostate antigen level, but tumor cells became resistant to this drug after a few months. The patient suffered under severe side effects. Melatonin was applied in one interval together with Amanita. It shows no additional side effect, but no additional advantage for the patient occurs. Discussion and Conclusion: Amanita is the drug for long term stabilization of a tumor patient. Fast occurrence of resistance was never observed so far. 5-alpha-reductase inhibitors can be applied in shorter intervals, with speedy development of resistance. Melatonin has no advantageous effect for this patient. Consequent monitoring for all therapy steps is recommended.

Amanita phalloides prostate CA tumor therapy 5-alpha-reductase inhibitor melatonin

References (14)

  1. 1 Melatonin: Physiological effects in humans [DOI]
  2. 2 Melatonin as a potential anticarcinogen for non-small-cell lung cancer [DOI]
  3. 3 Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality [DOI]
  4. 4 Anticancer and Immunomodulatory Effects of Lactobacillus plantarum LS/07, Inulin and Melatonin in NMU-induced Rat Model of Breast Cancer.
  5. 5 AGE SPECIFIC PROSTATE SPECIFIC ANTIGEN REFERENCE RANGES: POPULATION SPECIFIC [DOI]
  6. 6 Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial [DOI]
  7. 7 Circadian Dysrhythmias, Physiological Aberrations, and the Link to Skin Cancer [DOI]
  8. 8 Comparisons of the Efficacy and Safety of Finasteride and Dutasteride for Benign Prostatic Hyperplasia: A Network Meta-Analysis [DOI]
  9. 9 Switch the Tumor Off: From Genes to Amanita Therapy [DOI]
  10. 10 The new insight of prostate-specific antigen reduction during finasteride therapy in aging men [DOI]
  11. 11 Age‐associated increase of prostate‐specific antigen in a high level of men visiting urological clinics [DOI]
  12. 12 Borrelia Infection Appears as Chronic Lymphocytic Leukemia: Therapy with Amanita phalloides and Terebinthina laricina [DOI]
  13. 13 Role of 5α-Reductase Inhibitors in the Treatment of Advanced Prostatic Carcinoma [DOI]
  14. 14 Membrane Fluidity: About the Origin of Autoimmunity [DOI]

Cited by 3

Tumor Therapy with Amanita phalloides: Benefits and Limitation

Isolde Riede · Journal of Complementary and Alternative Medical Research · 2021

Showing 1 of 3 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

70

Page views

0

PDF downloads

45

Outbound clicks

3

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.